The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment
oleh: Shawn D Aaron, Katherine Vandemheen, Dean Fergusson, Mark FitzGerald, Francois Maltais, Jean Bourbeau, Roger Goldstein, Andrew McIvor, Meyer Balter, Denis O'Donnell
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2004-01-01 |
Deskripsi
BACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD).